ATN-161 (trifluoroacetate salt)

ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.

Product Specifications

CAS Number

[904763-27-5]

Product Name Alternative

ATN-161 TFA salt

UNSPSC

12352005

Target

Integrin

Type

Reference compound

Related Pathways

Cytoskeleton

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ATN-161-trifluoroacetate-salt.html

Purity

99.04

Solubility

DMSO : 1 mg/mL (ultrasonic) |H2O : 5 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

FC(F)(C(O)=O)F.O=C(N)C[C@@H](C(N)=O)NC([C@H](CS)NC([C@H](CO)NC([C@H](CC1=CNC=N1)NC([C@H]2N(C(C)=O)CCC2)=O)=O)=O)=O

Molecular Formula

C25H36F3N9O10S

Molecular Weight

711.67

References & Citations

[1]Stoeltzing O, et al. Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int J Cancer. 2003 Apr 20;104 (4) :496-503.|[2]Wang W, et al. The antiangiogenic effects of integrin alpha5beta1 inhibitor (ATN-161) in vitro and in vivo. Invest Ophthalmol Vis Sci. 2011 Sep 14;52 (10) :7213-20.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Citation 01

ACS Biomater Sci Eng. 2023 May 8;9 (5) :2524-2533.|Cell Prolif. 2021 Apr;54 (4) :e13012.|Colloids Surf B Biointerfaces. 2022 Feb:210:112227.|Stem Cell Res Ther. 2022 Jul 18;13 (1) :327.|ACS Nano. 2025 Jun 10;19 (22) :20564-20577.|Cancer Cell. 2019 Jan 14;35 (1) :64-80.e7. |J Adv Res. 2025 May 25:S2090-1232 (25) 00370-4.|Sci Signal. 2022 Dec 6;15 (763) :eabn2743.